Zobrazeno 1 - 10 of 35 pro vyhledávání: '"E F Smit"'
1
Akademický článek
Overall survival in EGFR mutated non-small-cell lung cancer patients treated with afatinib after EGFR TKI and resistant mechanisms upon disease progression.
Autor: A J van der Wekken, J L Kuiper, A Saber, M M Terpstra, J Wei, T J N Hiltermann, E Thunnissen, D A M Heideman, W Timens, E Schuuring, K Kok, E F Smit, A van den Berg, H J M Groen
Publikováno v: PLoS ONE, Vol 12, Iss 8, p e0182885 (2017)
To determine survival in afatinib-treated patients after treatment with first-generation EGFR tyrosine kinase inhibitors (TKIs) and to study resistance mechanisms in afatinib-resistant tumors.Characteristics and survival of patients treated with afat
Externí odkaz: https://doaj.org/article/93cb6fbdcf78436f94adb5f3693dd368
Zobrazit plný text záznamu
2
Akademický článek
Whole body PD-1 and PD-L1 positron emission tomography in patients with non-small-cell lung cancer
Autor: A. N. Niemeijer, D. Leung, M. C. Huisman, I. Bahce, O. S. Hoekstra, G. A. M. S. van Dongen, R. Boellaard, S. Du, W. Hayes, R. Smith, A. D. Windhorst, N. H. Hendrikse, A. Poot, D. J. Vugts, E. Thunnissen, P. Morin, D. Lipovsek, D. J. Donnelly, S. J. Bonacorsi, L. M. Velasquez, T. D. de Gruijl, E. F. Smit, A. J. de Langen
Publikováno v: Nature Communications, Vol 9, Iss 1, Pp 1-5 (2018)
Assessment of PD-1 and PD-L1 expression can be predictive of immunotherapy response in lung cancer. Here the authors assess the clinical toxicity, safety and quality of non-invasive imaging of PD-1 and PD-L1 expression in 13 patients with advanced lu
Externí odkaz: https://doaj.org/article/d775b429652c43478095f6b7bc6015c1
Zobrazit plný text záznamu
3
Quantification of [
Autor: E A, van de Stadt, M, Yaqub, A A, Lammertsma, A J, Poot, P R, Schober, R C, Schuit, E F, Smit, I, Bahce, N H, Hendrikse
Publikováno v: EJNMMI Research
Introduction Only a subgroup of non-small cell lung cancer (NSCLC) patients benefit from treatment using epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) such as afatinib. Tumour uptake of [18F]afatinib using positron emission
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::73a86a55f79011a69537a53110ef4fd3
https://pubmed.ncbi.nlm.nih.gov/32804306
Zobrazit plný text záznamu
4
Partial-volume correction in dynamic PET-CT: effect on tumor kinetic parameter estimation and validation of simplified metrics
Autor: M. C. F. Cysouw, S. V. S. Golla, V. Frings, E. F. Smit, O. S. Hoekstra, G. M. Kramer, R. Boellaard, on behalf of the QuIC-ConCePT Consortium
Publikováno v: EJNMMI Research
EJNMMI Research, 9(1). Springer Berlin
EJNMMI Research, Vol 9, Iss 1, Pp 1-11 (2019)
Cysouw, M C F, Golla, S V S, Frings, V, Smit, E F, Hoekstra, O S, Kramer, G M, Boellaard, R & QuIC-ConCePT Consortium 2019, ' Partial-volume correction in dynamic PET-CT : effect on tumor kinetic parameter estimation and validation of simplified metrics ', EJNMMI Research, vol. 9, no. 1, pp. 12 . https://doi.org/10.1186/s13550-019-0483-z
Background Partial-volume effects generally result in an underestimation of tumor tracer uptake on PET-CT for small lesions, necessitating partial-volume correction (PVC) for accurate quantification. However, investigation of PVC in dynamic oncologic
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f88fa6d17bddcf0a3fbe662ada60658
http://europepmc.org/articles/PMC6362178
Zobrazit plný text záznamu
5
Variability and Repeatability of Quantitative Uptake Metrics in
Autor: Mingzan, Zhuang, David Vállez, García, Gerbrand M, Kramer, Virginie, Frings, E F, Smit, Rudi, Dierckx, Otto S, Hoekstra, Ronald, Boellaard
Publikováno v: Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 60(5)
There is increased interest in various new quantitative uptake metrics beyond SUV in oncologic PET/CT studies. The purpose of this study was to investigate the variability and test-retest ratio (TRT) of metabolically active tumor volume (MATV) measur
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::dbcdf3835f029d234b0f13c2bbbd729b
https://pubmed.ncbi.nlm.nih.gov/30389824
Zobrazit plný text záznamu
6
Validation of [18F]FLT as a perfusion-independent imaging biomarker of tumour response in EGFR-mutated NSCLC patients undergoing treatment with an EGFR tyrosine kinase inhibitor
Autor: R. Iqbal, G. M. Kramer, V. Frings, E. F. Smit, O. S. Hoekstra, R. Boellaard, on behalf of the QuIC-ConCePT Consortium
Publikováno v: EJNMMI Research, 8:22. Springer Berlin
Iqbal, R, Kramer, G M, Frings, V, Smit, E F, Hoekstra, O S, Boellaard, R & on behalf of the QuIC-ConCePT Consortium 2018, ' Validation of [ 18 F]FLT as a perfusion-independent imaging biomarker of tumour response in EGFR-mutated NSCLC patients undergoing treatment with an EGFR tyrosine kinase inhibitor ', EJNMMI Research, vol. 8, 22 . https://doi.org/10.1186/s13550-018-0376-6
EJNMMI Research, Vol 8, Iss 1, Pp 1-10 (2018)
3′-Deoxy-3′-[18F]fluorothymidine ([18F]FLT) was proposed as an imaging biomarker for the assessment of in vivo cellular proliferation with positron emission tomography (PET). The current study aimed to validate [18F]FLT as a perfusion-independent
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1753cb198ef2ad8727d37459619e3255
https://research.vumc.nl/en/publications/f5e41778-417a-4e1e-b530-0f6740d96904
Zobrazit plný text záznamu
7
Validation of [
Autor: R, Iqbal, G M, Kramer, V, Frings, E F, Smit, O S, Hoekstra, R, Boellaard
Publikováno v: EJNMMI Research
Background 3′-Deoxy-3′-[18F]fluorothymidine ([18F]FLT) was proposed as an imaging biomarker for the assessment of in vivo cellular proliferation with positron emission tomography (PET). The current study aimed to validate [18F]FLT as a perfusion-
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::76be4812281e6694e0775d9215d3624d
https://pubmed.ncbi.nlm.nih.gov/29594931
Zobrazit plný text záznamu
8
Cost-Utility of Stepped Care Targeting Psychological Distress in Patients With Head and Neck or Lung Cancer
Autor: Annemieke van Straten, E. F. Smit, Veerle M.H. Coupé, Femke Jansen, Anna M. H. Krebber, C. René Leemans, Aartjan T.F. Beekman, Irma M. Verdonck-de Leeuw, Pim Cuijpers, Remco de Bree, Guus M Eeckhout, Annemarie Becker-Commissaris
Publikováno v: Journal of Clinical Oncology, 35(3), 314. American Society of Clinical Oncology
Journal of Clinical Oncology, 35(3), 314-324. American Society of Clinical Oncology
Cuijpers, P, Jansen, F, Krebber, A M H, Coupé, V M H, van Bree, R, Becker-Commissaris, A, Smit, E F, van Straten, A, Eeckhout, G M, Beekman, A T F, Leemans, C R & Verdonck-de Leeuw, I M 2017, ' Cost-Utility of Stepped Care Targeting Psychological Distress in Patients With Head and Neck or Lung Cancer ', Journal of Clinical Oncology, vol. 35, no. 3, pp. 314-325 . https://doi.org/10.1200/JCO.2016.68.8739
Jansen, F, Krebber, A M H, Coupé, V M H, Cuijpers, P, de Bree, R, Becker-Commissaris, A, Smit, E F, van Straten, A, Eeckhout, G M, Beekman, A T F, Leemans, C R & Verdonck-de Leeuw, I M 2017, ' Cost-Utility of Stepped Care Targeting Psychological Distress in Patients With Head and Neck or Lung Cancer ', Journal of Clinical Oncology, vol. 35, no. 3, pp. 314-324 . https://doi.org/10.1200/JCO.2016.68.8739
Journal of Clinical Oncology, 35(3), 314-325. American Society of Clinical Oncology
Purpose A stepped care (SC) program in which an effective yet least resource-intensive treatment is delivered to patients first and followed, when necessary, by more resource-intensive treatments was found to be effective in improving distress levels
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea22e610ff2475610dc7916cf581b8af
https://dspace.library.uu.nl/handle/1874/348368
Zobrazit plný text záznamu
9
2nd ESMO Consensus Conference on Lung Cancer: non-small-cell lung cancer first-line/second and further lines of treatment in advanced disease
Autor: Benjamin Besse, Cécile Le Péchoux, Gaetano Rocco, Wilfried Eberhardt, Walter Weder, Solange Peters, Antonio Marchetti, Peter Meldgaard, Dirk De Ruysscher, S. Peters, Rolf A. Stahel, E. Felip, Giulia Veronesi, Alex A. Adjei, Suresh Senan, Egbert F. Smit, Christophe Dooms, M. Nicolson, Keith M. Kerr, Jean-Yves Douillard, Lucio Crinò, Kenneth J. O'Byrne, Lukas Bubendorf, Paul Baas, P. Meldgaard, E. F. Smit, Corinne Faivre-Finn, Marianne Nicolson, P. Baas, A. A. Adjei, Silvia Novello, Paul De Leyn, Luis Paz-Ares, Tony Mok, Enriqueta Felip, Martin Reck, Martin J. Edelman, Paul Van Schil, Virginie Westeel, Konstantinos N. Syrigos, Eric Lim, Johan Vansteenkiste, Kostas N. Syrigos
Publikováno v: Besse, B, Adjei, A, Baas, P, Meldgaard, P, Nicolson, M, Paz-Ares, L, Reck, M, Smit, E F, Syrigos, K, Stahel, R, Felip, E, Peters, S & Panel Members 2014, ' 2nd ESMO Consensus Conference on Lung Cancer: non-small-cell lung cancer first-line/second and further lines of treatment in advanced disease ', Annals of Oncology, vol. 25, no. 8, pp. 1475-84 . https://doi.org/10.1093/annonc/mdu123
Besse, B, Adjei, A, Baas, P, Meldgaard, P, Nicolson, M, Paz-Ares, L, Reck, M, Smit, E F, Syrigos, K, Stahel, R, Felip, E & Peters, S 2014, ' 2nd ESMO Consensus Conference on Lung Cancer: non-small-cell lung cancer first-line/second and further lines of treatment in advanced disease ', Annals of Oncology, vol. 25, no. 8, pp. 1475-1484 . https://doi.org/10.1093/annonc/mdu123
Annals of Oncology, 25(8), 1475-1484. Oxford University Press
Annals of Oncology, vol. 25, no. 8, pp. 1475-1484
To complement the existing treatment guidelines for all tumour types, ESMO organises consensus conferences to focus on specific issues in each type of tumour. The 2nd ESMO Consensus Conference on Lung Cancer was held on 11-12 May 2013 in Lugano. A to
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb9b68d0beee0bfabbf49961f6680650
https://doi.org/10.1093/annonc/mdu123
Zobrazit plný text záznamu
10
Stepped care targeting psychological distress in head and neck cancer and lung cancer patients:a randomized, controlled trial
Autor: C.R. Leemans, Femke Jansen, Annemarie Becker-Commissaris, E. F. Smit, Birgit I. Witte, Aartjan T.F. Beekman, Pim Cuijpers, R. de Bree, Anne-Marie H Krebber, A. M. Eeckhout, A. van Straten, I.M. Verdonck-de Leeuw
Publikováno v: Krebber, A-M H, Jansen, F, Witte, B I, Cuijpers, P, Bree, R, Becker-Commissaris, A, Smit, E F, van Straten, A, Eeckhout, A M, Beekman, A T F, Leemans, C R & Verdonck-de Leeuw, I M 2016, ' Stepped care targeting psychological distress in head and neck cancer and lung cancer patients : a randomized, controlled trial ', Annals of Oncology, vol. 27, no. 9, pp. 1754-60 . https://doi.org/10.1093/annonc/mdw230
Annals of Oncology, 27(9), 1754
Annals of Oncology, 27(9), 1754-1760. Oxford University Press
Annals of Oncology, 27(9), 1754. Oxford University Press
Krebber, A M H, Jansen, F, Witte, B I, Cuijpers, P, de Bree, R, Becker-Commissaris, A, Smit, E F, van Straten, A, Eeckhout, A M, Beekman, A T F, Leemans, C R & Verdonck-de Leeuw, I M 2016, ' Stepped care targeting psychological distress in head and neck cancer and lung cancer patients: a randomized, controlled trial ', Annals of Oncology, vol. 27, no. 9, pp. 1754-1760 . https://doi.org/10.1093/annonc/mdw230
Annals of Oncology, 27(9), 1754-60. Oxford University Press
BACKGROUND: This study aimed to evaluate the efficacy of stepped care (SC) targeting psychological distress in head and neck cancer (HNC) and lung cancer (LC) patients.PATIENTS AND METHODS: Patients with untreated distress [Hospital Anxiety and Depre
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05b927a60335193f600cedfc02116bbd
https://research.vu.nl/en/publications/89c4120d-bdee-404a-b02c-5bc07a310007
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje